Molnupiravir, also known by its brand name Lagevrio, represents a important advancement in the fight against the virus. This oral antiviral medicine works by introducing errors into the viral genetic sequence, effectively preventing its duplication and progression within the patient. While first data suggested a considerable reduction in hospitaliz